-
EBMT China’s Voice | Team led by Yi Luo/Yibo Wu: Current Treatment Status and Prognosis of Acute Myeloid Leukemia with t(8;21) Chromosome Translocat
Acute myeloid leukemia (AML) with t(8;21)(q22;q22.1) is one subtype among AML with recurrent genetic abnormalities, characterized by the translocation between chromosome 8q22 and chromosome 21q22. This translocation leads to the fusion of the RUNX1 gene on 8q22 with the RUNX1T1 gene on 21q22, forming the RUNX1-RUNX1T1 fusion gene. From April 14th to 17th, 2024, the…
-
Professor Jun Guo Interprets the Updated CSCO Guidelines on Urothelial Carcinoma and Melanoma | 2024 CSCO Guideline Conference
The 2024 CSCO Guideline Conference, co-hosted by the Chinese Society of Clinical Oncology (CSCO) and the Beijing Hope Science Clinical Oncology Research Foundation, took place in Jinan on April 26-27. At the event, Professor Jun Guo from Peking University Cancer Hospital was interviewed by “Oncology Frontier.” He discussed significant updates in the new editions of…
-
Professor Rui Ge: Review and Outlook on Advances in Breast Cancer Treatment | Northern Breast Cancer Salon Annual Review
As time passes and seasons flow, we always embark on new journeys and endeavors through repeated reviews and outlooks. The annual review of the Northern Breast Cancer Salon and the discussion on the 2024 CSCO BC Guidelines update were held from January 5-6, 2024, in Beijing. “Oncology Frontier” specially interviewed Professor Rui Ge from East…
-
Professor Ying Yuan: Updates to the 2024 CSCO Guidelines for Colorectal Cancer – Enhancing Personalized Treatment from Pathology to Therapy
The 2024 update of the Chinese Society of Clinical Oncology (CSCO) Guidelines for the Diagnosis and Treatment of Colorectal Cancer has been released. The new edition incorporates the latest evidence-based medical developments, adds new biomarkers for colorectal cancer, enriches clinical treatment strategy options, and adjusts the recommendation levels for various treatment protocols. Oncology Frontier interviewed…
-
EAU24 Expert Commentary | Professor Fufu Zheng: NMIBC Postoperative Intravesical Therapy Strategies and Research Progress
Transurethral resection of bladder tumor (TURBt) is the primary treatment for non-muscle-invasive bladder cancer (NMIBC), but the postoperative tumor recurrence rate remains high, posing a significant clinical challenge. To prevent tumor recurrence, different intravesical therapies are administered post-TURBt based on the patient’s recurrence risk level. At the 2024 39th Annual European Association of Urology (EAU24)…
-
Hepatol Int丨Long-term Prognosis of Robotic Liver Resection for Hepatocellular Carcinoma is Safe and Effective
Primary liver cancer (PLC) is one of the most common cancers worldwide and a leading cause of cancer-related deaths, with hepatocellular carcinoma (HCC) accounting for about 85% of all PLC cases. Despite continuous advancements in medical technology, radical surgical resection of the primary tumor remains a key component of HCC treatment. Robotic liver resection (RLR)…
-
Professor Jun Zhu: Rapid Advances in Clinical Trials Usher in a New Era for Lymphoma Diagnosis and Treatment! | 2024 Nanjing Lymphoma Forum
Amidst the gentle breeze of early summer, the annual “Nanjing Lymphoma Forum” was grandly held in the historic city of Nanjing. This offline event gathered renowned experts in the field of lymphoma from both domestic and international spheres. Through lectures, case discussions, and other formats, the forum facilitated exchanges on the latest achievements and developments…
-
EAU24 On-Site Highlights | Professor Wei Zhai: Advances in Urological Tumor Research to Improve Patient Prognosis
The 39th Annual European Association of Urology (EAU24) Congress took place from April 5-8, 2024, in Paris, France, focusing on global urological oncology hotspots and the forefront of Chinese urological research. At the event, “Oncology Frontier” invited Professor Wei Zhai from Renji Hospital, affiliated with Shanghai Jiao Tong University School o,(f Medicine, to share his…
Connecting Medical Expertise through Media